Series Introduction | |
Preface | |
Contributors | |
The Changing Face of Heart Failure | p. 1 |
Epidemiology of Congestive Heart Failure | p. 9 |
The Sympathetic Nervous System and Myocardial Adrenoceptor Function and Regulation in Cardiac Failure | p. 29 |
Pathophysiology of Heart Failure: Neuroendocrine Factors | p. 49 |
Left Ventricular Remodeling | p. 71 |
Assessment of Therapeutic Efficacy in Patients with Chronic Heart Failure | p. 93 |
Diuretics for the Treatment of Heart Failure | p. 103 |
Cardiac Glycosides in the Treatment of Heart Failure | p. 119 |
Vasodilators in the Therapeutics of Heart Failure | p. 143 |
ACE Inhibitors in the Treatment of Heart Failure | p. 169 |
[beta]-Adrenoceptor Agonists and Partial Agonists for Heart Failure | p. 185 |
The Paradox of [beta]-Adrenergic Blockers for the Management of Congestive Heart Failure | p. 213 |
Dopamine Receptor Agonists in Heart Failure | p. 251 |
Calcium Entry Blockers in Congestive Heart Failure and in Asymptomatic Left Ventricular Dysfunction | p. 287 |
Phosphodiesterase Inhibitors, Calcium Sensitizers, and Ion Channel Active Agents | p. 303 |
Heart Transplantation | p. 323 |
Sudden Death and Arrhythmias Complicating Heart Failure | p. 343 |
Index | p. 373 |
Table of Contents provided by Blackwell. All Rights Reserved. |